Lotus Response to the Coronavirus (COVID-19)
At Lotus Clinical Research, the safety of our patients, employees and customers remains our highest priority. In the coming weeks and months, in accordance with
March 10, 2020
Network of Sites
Lotus is a science-driven, full-service CRO with a number of unique qualities that no other CRO can provide. One particular differentiator is that we are under common ownership with Evolution Research Group (ERG), which is a clinical site organization with 20+ wholly-owned clinical research sites around the US.
These sites conduct research across all indications in the following Therapeutic Areas:
- Psychiatry
- Neurology
- Pain
- Addiction
- Phase 1 / Healthy Volunteers
- Renal and Hepatic Impairment
- Metabolic Disorders
- Endocrinology
Because of this connection to ERG, Lotus’ Sponsors benefit from one-stop shopping for:
- Molecule-to-market solutions
- Full-service, specialty CRO
- Industry-leading, Early Phase expertise
- Top CNS/Pain/Metabolic Investigators
- Placebo Mitigation Training
- Rater Training
- Compliance training
- Highly trained clinical research staff
- Harmonized SOPs & CAPA processes
- Quality clinical unit, overnight facilities
- Local & centralized recruitment expertise
- Technology-driven management processes